Prevalence of mastocytosis and hymenoptera venom allergy in the United States

Background : Mastocytosis is a risk factor for hymenoptera venom anaphylaxis (HVA). Current guidelines recommend measuring tryptase in HVA patients and that those with mastocytosis pursue lifelong venom immunotherapy (VIT). Available data on HVA and mastocytosis largely derives from European single-center studies and the prevalence of HVA with and without mastocytosis in the United States (US) is unknown. Objective : We sought to determine the prevalence of HVA and mastocytosis in the US using an insurance claims database and evaluate the impact of mastocytosis on VIT in HVA patients in a US cohort. Methods :The IBM Watson Database, consisting of insurance claims from approximately 27 million US patients in 2018, was queried to identify patients with HVA and/or mastocytosis. Further, a retrospective study of 161 patients undergoing VIT between 2015 – 2018 at the University of Michigan (U-M) was conducted. Results :In the IBM Watson Database, the prevalence of HVA was 167 per 100,000 (0.167%) and the prevalence of mastocytosis 10 per 100,000 (0.010%) overall and 97 per 100,000 (0.097%) among those with HVA. Mastocytosis showed a 9.7-fold increase among HVA patients versus the general population. In the U-M cohort, 2.6% of VIT patients had mastocytosis. Tryptase level did not correlate with venom reaction severity but was higher in patients with systemic VIT reactions. Conclusions :We observed a lower US HVA prevalence than previously reported. Mastocytosis was more common in US HVA patients, though at lower rates than previously reported. In VIT patients there was no correlation between tryptase level and reaction severity. Key words :Tryptasevenom allergyvenom immunotherapyanaphylaxismastocytosismast cell activation syndromemast cell disease Abbreviations Hymenoptera venom allergyHVAUnited StatesUSVenom immunotherapyVITMast Cell DiseaseMCDAmerican Academy of Allergy, Asthma, and ImmunologyWOS:000717466600002Scopus - Affiliation ID: 60105072PMID: 33895259Science Citation Index ExpandedQ1ArticleUluslararası işbirliği ile yapılan - EVETKasım2021YÖK - 2021-2

Epidemiological findings on interventional cardiology procedures during the COVID-19 pandemic: A multi-center study

Background: The rates of in-hospital mortality following percutaneous interventional procedures (PIP) during the COVID-19 pandemic period compared to the non-pandemic period has not been reported so far. Methods: We retrospectively enrolled all consecutive patients admitted for PIP across five centers from February 2020 to May 2020. Results: A total of 4092 PIP were performed during the reference periods. The total number of procedures dropped from 2380 to 1712 (28.0% reduction). Overall in-hospital mortality increased from 1.1% in 2019, to 2.6% in 2020 (63% relative increase). Conclusion: During the COVID-19 pandemic, in-hospital all-cause mortality significantly increased in patients admitted for cardiological PIP

Global Monitoring of Atmospheric Trace Gases, Clouds and Aerosols from UV/vis/NIR Satellite Instruments: Currents Status and Near Future Perspectives

A new generation of UV/vis/near‐IR satellite instruments like GOME (since 1995), SCIAMACHY (since 2002), OMI (since 2004), and GOME‐2 (since 2006) allows to measure several important stratospheric and tropospheric trace gases like O_3, NO_2, OClO, HCHO, SO_2, BrO, and H_2O as well as clouds and aerosols from space. Because of its extended spectral range, the SCIAMACHY instrument also allows the retrieval of Greenhouse gases (CO_2, CH_4) and CO in the near IR. Almost all of the tropospheric trace gases are observed by these instruments for the first time. From satellite data it is possible to investigate the temporal and spatial variation. Also different sources can be characterised and quantified. The derived global distributions can serve as input and for the validation of atmospheric models. Here we give an overview on the current status of these new instruments and data products and their recent applications to various atmospheric and oceanic phenomena

Hepatocellular carcinoma in Pakistan: where do we stand?

Context: From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for hepatocellular carcinoma (HCC) in Pakistan. Afterwards, a shift in HCC etiology was observed with a steady rise in hepatitis C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotype, is also most frequent in HCV related HCC. There was an increase in the proportion of non-B non-C (NBNC) HCC cases as well, which might be attributed to an increase in non-alcoholic fatty liver disease. Evidence Acquisition: The age-standardized rate for HCC is 7.64/100 000 in males and 2.8/100 000 in females. Male to female ratio is 3.6:1. Usual age of presentation is in the fifth and sixth decade. Most patients present with advanced disease, as they are not in a regular surveillance program. This is more so for patients with NBNC chronic liver disease. As many sonologists in Pakistan are practicing without sufficient training to pick up early lesions, alpha-fetoprotein is still recommended to compliment ultrasound in the surveillance of HCC. Results: Majority of HCC patients present with nonresectable disease. Interventions such as transarterial chemoembolization, radiofrequency ablation, resection and chemotherapy including sorafenib are available in selected centers. Pakistan appears to be in an area of intermediate endemicity for HCC. There is a need for population based epidemiological studies to estimate the exact disease burden. Conclusions: Measures to prevent the spread of hepatitis C and B can slow down the epidemic rise in the incidence of HCC in the coming decades. There is a need to implement a proper surveillance program to identify HCC cases at an early stage

Multiplex PCR Assay to Detect High Risk Lineages of <i>Salmonella</i> Typhi.

Background: Enteric fever infections caused by Salmonella serovars Typhi and Paratyphi A remain a significant public health issue, with up to 20 million infections per year. Increasing rates of antibiotic resistant isolates have rendered many first-line antibiotics potentially ineffective. Current methods of identification require culture for several days followed by whole-genome sequencing (WGS) to determine the specific lineage. Genotype 4.3.1 (H58) is the main circulating lineage of S. Typhi in many South Asian countries and is associated with high levels of antibiotic resistance. The emergence and spread of extensively drug resistant (XDR) typhoid has increased the need for a rapid molecular test to identify and track these high-risk lineages for treatment decisions, surveillance, and vaccine prioritisation. Methods: Utilising WGS datasets that have identified SNPs specific for H58 and XDR S. Typhi lineages, we designed primers to incorporate these mutations as robust genomic markers of clinical significance and optimised a single multiplex PCR assay. Genomic DNA was extracted from pure cultures of S. Typhi, non-Typhi Salmonella and non-Salmonella samples. Results: Initial testing of our assay showed 100% specificity of our targets for the identification of S. Paratyphi A and the H58 and Pakistan XDR lineages of S. Typhi, with no false positive amplification with non-Typhi Salmonella or non-Salmonella samples. Our assay also identified 13/75 samples as S. Paratyphi A which had previously been identified as S. Typhi by MALDITOF MS, all of which were confirmed by WGS. Conclusion: This DNA-based diagnostic assay can offer a cheaper alternative to WGS for sensitive and specific rapid detection of risk stratified S. Typhi and S. Paratyphi A. With further testing planned in typhoid fever endemic regions, this assay could be used directly on both clinical and environmental samples for rapid diagnosis and surveillance

Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study

<p>Abstract</p> <p>Background</p> <p>Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The hepatitis C virus is a small, enveloped, single-stranded, positive sense RNA virus with a large genetic heterogeneity. Isolates have been classified into at least eleven major genotypes, based on a nucleotide sequence divergence of 30-35%. Genotypes 1, 2 and 3 circulate around the world, while other genotypes are mainly restricted to determined geographical areas. Genotype determination of HCV is clinically valuable as it provides important information which can be used to determine the type and duration of therapy and to predict the outcome of the disease.</p> <p>Results</p> <p>Plasma samples were collected from ninety seven HCV RNA positive patients admitted to two large medical laboratory centers in Isfahan province (Iran) from the years 2007 to 2009. Samples from patients were subjected to HCV genotype determination using a PCR based genotyping kit. The frequency of HCV genotypes was determined as follows: genotype 3a (61.2%), genotype 1a (29.5%), genotype 1b (5.1%), genotype 2 (2%) and mixed genotypes of 1a+3a (2%).</p> <p>Conclusion</p> <p>Genotype 3a is the most frequent followed by the genotype 1a, genotype 1b and genotype 2 in Isfahan province, Iran.</p

Global Monitoring of Atmospheric Trace Gases, Clouds and Aerosols from UV/vis/NIR Satellite Instruments: Currents Status and Near Future Perspectives

A new generation of UV/vis/near‐IR satellite instruments like GOME (since 1995), SCIAMACHY (since 2002), OMI (since 2004), and GOME‐2 (since 2006) allows to measure several important stratospheric and tropospheric trace gases like O_3, NO_2, OClO, HCHO, SO_2, BrO, and H_2O as well as clouds and aerosols from space. Because of its extended spectral range, the SCIAMACHY instrument also allows the retrieval of Greenhouse gases (CO_2, CH_4) and CO in the near IR. Almost all of the tropospheric trace gases are observed by these instruments for the first time. From satellite data it is possible to investigate the temporal and spatial variation. Also different sources can be characterised and quantified. The derived global distributions can serve as input and for the validation of atmospheric models. Here we give an overview on the current status of these new instruments and data products and their recent applications to various atmospheric and oceanic phenomena